To investigate whether BCAA catabolism is critical for glutamate production in GBM cells, we quantified the cellular glutamate concentration with LC-MS/MS and found that the inhibition of BCAT1 significantly decreased the level of glutamate in GBM cells (Figure 3G). Here, BCAT1 is linked to glioblastoma.